Keith Berelowitz (Director of Operations)
A scientist by training, Keith has worked in clinical research (academic and commercial) for over 14 years, having spent the majority of that period working for Richmond Pharmacology. In his role as Director of Operations at Richmond Pharmacology he is focused on the efficient conduct of all functions within the company whilst ensuring maintenance of quality standards.
Having played an operational role in over 150 studies, across the commercial, project and recruitment related management of these studies, his specialist area of interest has focused on the assessment and understanding of the feasibility of conducting early phase patient trials in a phase I environment. Keith has worked with a number of sponsors advising them on the viability of conducting such trials within the UK, a number of which have gone on to be conducted successfully with Richmond Pharmacology.
He is a member of the National Research Ethics Service Phase I Advisory Group (Health Research Authority, UK), the Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI, UK), Chairperson of the EUCROF Early Phase Working Group, the UK representative of the EUCROF Extended Executive Board, and a Member of the Executive Board of the Clinical Contract Research Association (CCRA).